期刊文献+

β阻滞剂治疗慢性心力衰竭的应用进展 被引量:3

Application Progress of β-blocker Therapy in Chronic Heart Failure
下载PDF
导出
摘要 患者出现慢性心力衰竭后其交感神经系统活性会有不同程度的提高,且随着患病时间的推进可能会引发心血管系统功能恶化,使用β受体阻滞剂治疗可以有效抑制神经内分泌活性防止病情恶化。在慢性心力衰竭的治疗方面β受体阻滞剂已经得到了广泛应用,为了加深对β受体阻滞剂的认识,我国进行了大量的临床研究工作,临床实践经验丰富。有研究表明,合理的使用β受体阻滞剂对慢性心力衰竭患者进行治疗能够有效改善其预后。 Patients with chronic heart failure had different degrees of activity to improve their sympathetic nervous system, and with the advance of sick time may cause deterioration of the cardiovascular system, the use of β ̄blocker therapy can effectively make neuroendocrine activity in patients with suppressed to achieve the purpose of preventing disease progression. In the treat-ment of chronic heart failure β ̄blockers have been widely used, in order to deepen our under-standing of β ̄blockers have done a lot of clinical research, clinical practice experience. Studies have shown that the use of β ̄blockers and reasonable for the treatment of patients with chronic heart failure can improve their prognosis.
作者 张裕宝
机构地区 来宾市中医医院
出处 《现代诊断与治疗》 CAS 2015年第3期510-511,551,共3页 Modern Diagnosis and Treatment
关键词 慢性心力衰竭 Β受体阻滞剂 应用进展 Application Progress chronic heart failure β-blockers
  • 相关文献

参考文献20

二级参考文献150

共引文献99

同被引文献41

  • 1曲秀芬,喜杨,于彦伟,王馥,李晶洁,黄永麟.心肌梗死后神经生长因子的动态表达及其与交感神经重构的关系[J].中华心血管病杂志,2004,32(12):1135-1138. 被引量:12
  • 2王宏琳.美托洛尔与培哚普利联合治疗慢性心力衰竭[J].中国医药导报,2007,4(03Z):56-56. 被引量:10
  • 3谭碧峰,黄友良,俞群军,俞家贤,陆胜,凌莎.培哚普利、螺内酯、美托洛尔联合应用治疗充血性心力衰竭的临床研究[J].医学临床研究,2007,24(2):347-348. 被引量:4
  • 4Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990 - 2013 : a systematic sub- national analysis for the Global Burden of Disease Study 2013 [ J]. Lancet,2016,387 ( 10 015) :251 - 272.
  • 5胡嘉禄,颜彦,侯月梅.干预交感神经治疗慢性心力衰竭研究[J].中华临床医师杂志:电子版,2013,7(24):11739-11741.
  • 6Qin F, Vulapalli RS, Stevens SY, et al. Loss of cardiac sym- pathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF [ J ]. Am J Physiol Heart Circ Physiol, 2002,282 ( 1 ) : H363 - H371.
  • 7Kimura K, Kanazawa H, Ieda M, et al. Norepinephrine-in- duced nerve growth factor depletion causes cardiac sympa- thetic denervation in severe heart failure [ J ]. Auton Neuros- ci,2010,156(1 -2) :27 -35.
  • 8Sano H, Kasama S, Fujimoto S, et al. Effects of statin therapy on cardiac sympathetic nerve activity and left ventricular re- modeling in patients with chronic heart failure:a propensity score-matched analysis [ J]. Medicine(Baltimore) ,2014,93 (27) :e214.
  • 9Wang HJ, Wang W, Cornish KG, et al. Cardiac sympathetic afferent denervation attenuates cardiac remodeling and im- proves cardiovascular dysfunction in rats with heart failure [ J ]. Hypertension, 2014,64 ( 4 ) :745 - 755.
  • 10Ma L, Cui B, Shao Y, et al. Electroacupuncture improves cardiac function and remodeling by inhibition of sympatho- excitation in chronic heart failure rats [ J ]. Am J Physiol Heart Cire Physiol,2014,306(10) :H1 464 - H1 471.

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部